Red X iconGreen tick iconYellow tick icon

Contact Details

Research Assistant
PharmD PhD
Research summary
Molecular and cellular neuroscience, angiogenesis and tumor progression.


Barzegar-Fallah, A., Alimoradi, H., Dunlop, J. L., Torbati, E., & Baird, S. K. (2023). Serotonin type-3 receptor antagonists selectively kill melanoma cells through classical apoptosis, microtubule depolymerisation, ERK activation, and NF-κB downregulation. Cell Biology & Toxicology, 39, 1119-1135. doi: 10.1007/s10565-021-09667-0 Journal - Research Article

Barzegar-Fallah, A., Gandhi, K., Rizwan, S. B., Slatter, T. L., & Reynolds, J. N. J. (2022). Harnessing ultrasound for targeting drug delivery to the brain and breaching the blood–brain tumour barrier. Pharmaceutics, 14(10), 2231. doi: 10.3390/pharmaceutics14102231 Journal - Research Other

Gandhi, K., Barzegar-Fallah, A., Banstola, A., Rizwan, S. B., & Reynolds, J. N. J. (2022). Ultrasound-mediated blood-brain barrier disruption for drug delivery: A systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies. Pharmaceutics, 14, 833. doi: 10.3390/pharmaceutics14040833 Journal - Research Article

Alimoradi, H., Thomas, A., Lyth, D. D. B., Barzegar-Fallah, A., Matikonda, S. S., Gamble, A. B., & Giles, G. I. (2022). SMA-BmobaSNO: An intelligent photoresponsive nitric oxide releasing polymer for drug nanoencapsulation and targeted delivery. Nanotechnology, 33, 195101. doi: 10.1088/1361-6528/ac4eb0 Journal - Research Article

Barzegar-Fallah, A., Houlton, J., Barwick, D., Shavandi, A., Ali, M. A., Clarkson, A. N., & Alimoradi, H. (2021). From barriers to bridges: Glycans in naonparenteral nanomedicines. In P. Kesharwani, S. Taurin & K. Greish (Eds.), Theory and applications of nonparenteral nanomedicines. (pp. 467-487). London, UK: Elsevier. doi: 10.1016/B978-0-12-820466-5.00019-3 Chapter in Book - Research

Back to top